LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.22 | 27.76 | 1406 | 4125 | 0.3409 | 0.7228 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.22 | 27.76 | 1504 | 4125 | 0.3646 | 0.7390 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.22 | 27.76 | 1614 | 4125 | 0.3913 | 0.7561 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.93 | 27.76 | 1223 | 4421 | 0.2766 | 0.6778 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.93 | 27.76 | 1431 | 4421 | 0.3237 | 0.7142 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.93 | 27.76 | 1525 | 4421 | 0.3449 | 0.7292 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.93 | 27.76 | 1638 | 4421 | 0.3705 | 0.7461 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.63 | 27.76 | 1278 | 4818 | 0.2653 | 0.6732 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.63 | 27.76 | 1461 | 4818 | 0.3032 | 0.7036 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.63 | 27.76 | 1543 | 4818 | 0.3203 | 0.7162 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.63 | 27.76 | 1691 | 4818 | 0.3510 | 0.7374 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.33 | 27.76 | 1283 | 5117 | 0.2507 | 0.6642 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.33 | 27.76 | 1500 | 5117 | 0.2931 | 0.6991 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.33 | 27.76 | 1578 | 5117 | 0.3084 | 0.7106 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.33 | 27.76 | 1737 | 5117 | 0.3395 | 0.7326 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.04 | 27.76 | 1330 | 5365 | 0.2479 | 0.6644 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.04 | 27.76 | 1568 | 5365 | 0.2922 | 0.7009 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.04 | 27.76 | 1571 | 5365 | 0.2928 | 0.7013 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.04 | 27.76 | 1795 | 5365 | 0.3345 | 0.7315 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 54.74 | 27.76 | 1246 | 5606 | 0.2222 | 0.6434 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 54.74 | 27.76 | 1581 | 5606 | 0.2820 | 0.6953 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 54.74 | 27.76 | 1583 | 5606 | 0.2824 | 0.6956 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 54.74 | 27.76 | 1845 | 5606 | 0.3291 | 0.7298 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 56.45 | 27.76 | 1255 | 5745 | 0.2184 | 0.6412 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 56.45 | 27.76 | 1609 | 5745 | 0.2801 | 0.6950 | MN20160318_Q01 | E05 |